I agree that we should have a clear “hypothesis” that we should attempt to test. But I would put the emphasis on ‘clear,’ and to me that means being very specific in identifying: 1) a measureand (mean, median, geometric mean, variance, absolute, ratio, etc.), 2) what exactly we mean by comparable (same instrument over time, different instruments, different labs…), and 3) a quantitative measure of utility/success.
So, for example: “Our stakeholders need to be able to use flow cytometry to measure the geometric mean number of GFP molecules (absolute) per cell, with comparability across different labs and instruments with 1.2-fold or better geometric standard deviation. Can we develop a method, using fluorescent beads as a calibrant, that would meet this need?”
Now, in that example, I intentionally picked a target that I think many of you would be very skeptical of – so the answer to that one is probably, “No.”
So, a more realistic example, might be: “Our stakeholders need to be able to use flow cytometry to measure the ratio of two bacterial cell populations’ geometric mean GFP copy number, with comparability across different labs and instruments with 2-fold or better geometric standard deviation. Can we develop a method, using fluorescent beads as a calibrant, that would meet this need?”
I think if we can make a list of specific, needs-driven hypothesis statements along the lines of these examples, it will help us communicate with each other more clearly, and provide specific targets that we can think about addressing.
But before going this way, I would like to get consensus from the group. This is, after all, my first week of active participation, so it may be that the group already has an alternate (but equally clear) way to state a set of potential objectives/hypotheses.
So, I ask all of you to please respond with a Yes/No/other on the question of whether you think a list of needs-driven hypothesis statements, similar to my examples, is the right way to go.
Thanks-
--
You received this message because you are subscribed to the Google Groups "SBSC Flow Cytometry Working Group" group.
To unsubscribe from this group and stop receiving emails from it, send an email to
sbsc-flow-cytom...@googlegroups.com.
To post to this group, send email to
sbsc-flow...@googlegroups.com.
Visit this group at
https://groups.google.com/group/sbsc-flow-cytometry.
To view this discussion on the web visit
https://groups.google.com/d/msgid/sbsc-flow-cytometry/7257B42E-54C2-41A0-8B6A-FA29CFA5A130%40stanford.edu.
For more options, visit https://groups.google.com/d/optout.
Some additional comments on Ariel’s comments:
1) “…calibration of fluorescent protein expression to the Spherotech beads cannot be used to compare measurements from different instruments or in different labs.” Taking this as a general statement, I would disagree with it. The key question to me is not whether or not some method/calibrant can be used to compare different measurements, but how well it allows you to compare. So, for this case, I think Spherotech beads CAN be used to compare measurements from different instruments/labs, but it may be that the level of comparability it would give you is 1000-fold geometric standard deviation (or pick your favorite quantitative measure of comparability), which would really not be that useful.
With regard to fluorescent protein beads: The fluorescent properties of a molecule (protein, fluorescein, etc.) are not just determined by the molecule, but also by the medium it is in. So, GFP in a bead is not going to have the same excitation and emission spectra as GFP in an E. coli. So, qualitatively, there is no difference between GFP beads and Rainbow beads. Quantitatively, there probably is a difference: the GFP-beads spectra is likely to be closer than the Rainbow-beads spectra to the GFP-coli spectra. But whether or not that makes the difference between ‘good enough’ and ‘not good enough’ depends on the details – starting with what level of comparability do our stakeholders need?
There is a story about German and American nuclear scientists comparing notes after WWII. The German said, “The German program was very much superior to the American program. We were able to enrich uranium so that it was nearly pure U-235.” The American responded, “We figured out what level of enrichment we would need for a reliable bomb, and we stopped there.”
From: sbsc-flow...@googlegroups.com [mailto:sbsc-flow...@googlegroups.com]
On Behalf Of Ariel Haim Hecht
Sent: Thursday, December 08, 2016 6:54 PM
To: sbsc-flow...@googlegroups.com
Subject: [sbsc-fc] Proposing hypotheses and designing experiments
Hi all,
--
To view this discussion on the web visit https://groups.google.com/d/msgid/sbsc-flow-cytometry/BY1PR09MB04533935C36A44E0B73D5295E7870%40BY1PR09MB0453.namprd09.prod.outlook.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/sbsc-flow-cytometry/A57B5022-04FB-4D3B-A94D-063250127157%40stanford.edu.
To view this discussion on the web visit https://groups.google.com/d/msgid/sbsc-flow-cytometry/CAAXZg%3DYYNNG7TJay-y4%3Dfsnny64cYBupBTEh9POV%2Bfw0jprCpA%40mail.gmail.com.
From Paul DeRose (Fluorescence Guy at NIST) in response to my question on whether there are fluorescent beads that are NIST traceable:
“Yes, we now offer ERF assignments to members of the Quantitative Flow Cytometry Consortium.
This is being done as individual CRADAs with each company interested, all calibration bead manufacturers so far.
We assign the mean ERF units/bead. The ERF units are the number of molecules of reference fluorophore
corresponding to the fluorescence intensity of the bead. The SI unit is moles of fluorophore. During this process
we also measure the bead concentration and fluorophore concentration of reference solutions,
both traceable to moles/dm^3.
Note that we do not have a calibration bead SRM.
We are instead certifying the ERF values for the customer’s beads.”
To view this discussion on the web visit https://groups.google.com/d/msgid/sbsc-flow-cytometry/07F2BADD-6A12-4BA9-B9C5-FA28AB41CF26%40stanford.edu.